POSSIBLE IMMUNE-MEDIATED DISORDERS ASSOCIATED WITH ALLOPURINOL THERAPY

被引：0
|
作者：
PEDROIA, V
机构：
来源：
CANINE PRACTICE | 1981年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
引用
收藏
页码：19 / &
相关论文
共 50 条
  • [41] Immune-Mediated Disorders Affecting the Spinal Cord and the Spine
    Gina S. Perez Giraldo
    Jorge G. Ortiz Garcia
    Current Neurology and Neuroscience Reports, 2021, 21
  • [42] Chronic immune-mediated Neuropathies - Diagnostics and Therapy
    Grimm, Alexander
    Axer, Hubertus
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2018, 86 (07) : 439 - 450
  • [43] Update on therapy of chronic immune-mediated neuropathies
    Chiara Briani
    Dario Cocito
    Marta Campagnolo
    Pietro Emiliano Doneddu
    Eduardo Nobile-Orazio
    Neurological Sciences, 2022, 43 : 605 - 614
  • [44] Gene therapy in immune-mediated diseases of the eye
    Pleyer, U
    Ritter, T
    PROGRESS IN RETINAL AND EYE RESEARCH, 2003, 22 (03) : 277 - 293
  • [45] Therapy of immune-mediated disease in small animals
    Dunn, J
    IN PRACTICE, 1998, 20 (03) : 147 - +
  • [46] The Use of Monoclonal Antibodies in Immune-Mediated Hematologic Disorders
    Dierickx, Daan
    Beke, Emilie
    Devos, Timothy
    Delannoy, Andre
    MEDICAL CLINICS OF NORTH AMERICA, 2012, 96 (03) : 583 - +
  • [47] New treatment options for immune-mediated hematological disorders
    Dierickx, Daan
    De Rycke, Anja
    Vanderschueren, Steven
    Delannoy, Andre
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2008, 19 (08) : 579 - 586
  • [48] Abbreviated dose rituximab for immune-mediated hematological disorders
    Fairweather, Helen
    Tuckfield, Annabel
    Grigg, Andrew
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (07) : 554 - 557
  • [49] THE ROLE OF THERAPEUTIC APHERESIS IN THE TREATMENT OF IMMUNE-MEDIATED DISORDERS
    Rafajlovski, A.
    Ostojic, G.
    Todorovic, M.
    Balint, B.
    Jevtic, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 683 - 683
  • [50] Advances in Therapies of Cerebellar Disorders: Immune-Mediated Ataxias
    Hadjivassiliou, Marios
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2019, 18 (06) : 423 - 431
12345